Compare $LNSR vs $OM | Chartloom

Compare

$LNSR vs $OM

LENSAR Inc · Outset Medical Inc

LNSR

LENSAR Inc

Outset Medical Inc

Compare $LNSR vs $OM

Comparing LENSAR Inc and Outset Medical Inc

LNSRLENSAR Inc

OMOutset Medical Inc

LNSRLENSAR Inc

Market cap

$78M

P/E (TTM)

9.46x

Forward P/E (NTM)

—

Forward P/S (NTM)

1.12x

Rev growth (TTM)

3.3%

YTD performance

-45.1%

52W performance

-47.7%

FCF yield

-9.4%

OMOutset Medical Inc

Market cap

$75M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.56x

Rev growth (TTM)

-1.3%

YTD performance

9.5%

52W performance

-74.4%

FCF yield

-51.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LNSR

Detailed metrics comparison

LNSR

LENSAR Inc

Outset Medical Inc

Market Cap

LNSR$78M

OM$75M

Enterprise Value

LNSR$65M

OM$138M

Price

LNSR$6.37

OM$4.05

P/E Ratio

LNSR9.46x

OMN/A

P/S Ratio

LNSR1.30x

OM0.64x

EV/Sales

LNSR1.07x

OM1.17x

EV/EBITDA

LNSR24.86x

OM0.00x

P/B Ratio

LNSR2.89x

OM0.77x

P/FCF Ratio

LNSRN/A

OMN/A

EV/FCF

LNSR-8.82x

OM-3.56x

PEG Ratio

LNSRN/A

OMN/A

Forward P/E (NTM)

LNSRN/A

OMN/A

Forward P/S (NTM)

LNSR1.12x

OM0.56x

Revenue (TTM)

LNSR$60M

OM$118M

Revenue Growth (YoY)

LNSR3.3%

OM-1.3%

Forward Rev Growth

LNSR20.6%

OM10.5%

Gross Margin (TTM)

LNSR46.4%

OM41.8%

Operating Margin (TTM)

LNSR3.1%

OM0.0%

EBITDA Margin (TTM)

LNSR-7.8%

OM-53.2%

Net Margin (TTM)

LNSR25.7%

OM-63.1%

FCF Margin (TTM)

LNSR-12.2%

OM-33.0%

Net Income (TTM)

LNSR$16M

OM$-74M

FCF (TTM)

LNSR$-7M

OM$-39M

EPS (TTM)

LNSR$0.67

OM-$3.99

ROE (TTM)

LNSR149.7%

OM-6225.0%

ROA (TTM)

LNSR50.0%

OM-2875.0%

ROIC (TTM)

LNSR149.7%

OM-3438.0%

Cash

LNSR$14M

OM$35M

Debt

LNSR$0

OM$98M

Net Cash/Debt

LNSR$14M

OM$-63M

Current Ratio (TTM)

LNSR2.39x

OM5.19x

Quick Ratio (TTM)

LNSR1.03x

OM4.02x

Debt/Equity (TTM)

LNSR0.00x

OM1.02x

Debt/Assets (TTM)

LNSR0.0%

OM0.0%

Interest Coverage (TTM)

LNSRN/A

OMN/A

Net Debt/EBITDA (TTM)

LNSR0.00x

OM0.00x

Beta

LNSR1.01

OM2.01

52W Performance

LNSR-47.7%

OM-74.4%

YTD Performance

LNSR-45.1%

OM9.5%

% from 52W High

LNSR-50.8%

OM-74.9%

% from 52W Low

LNSR28.7%

OM42.6%

Asset Turnover (TTM)

LNSR0.87x

OM0.46x

FCF Yield (TTM)

LNSR-9.4%

OM-51.8%

Earnings Yield (TTM)

LNSR19.8%

OM-98.9%

Dividend Yield (TTM)

LNSRN/A

OMN/A

Rule of 40

LNSR-8.9

OM-34.3

EV/GP/RG

LNSR0.15

OM0.04

Ticker research

View LNSR research View OM research

Metric	LNSR LENSAR Inc	OM Outset Medical Inc
Market & Valuation
Market Cap	$78M	$75M
Enterprise Value	$65M	$138M
Price	$6.37	$4.05
P/E Ratio	9.46x	N/A
P/S Ratio	1.30x	0.64x
EV/Sales	1.07x	1.17x
EV/EBITDA	24.86x	0.00x
P/B Ratio	2.89x	0.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.82x	-3.56x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.12x	0.56x
Revenue & Growth
Revenue (TTM)	$60M	$118M
Revenue Growth (YoY)	3.3%	-1.3%
Forward Rev Growth	20.6%	10.5%
Profitability
Gross Margin (TTM)	46.4%	41.8%
Operating Margin (TTM)	3.1%	0.0%
EBITDA Margin (TTM)	-7.8%	-53.2%
Net Margin (TTM)	25.7%	-63.1%
FCF Margin (TTM)	-12.2%	-33.0%
Net Income (TTM)	$16M	$-74M
FCF (TTM)	$-7M	$-39M
EPS (TTM)	$0.67	-$3.99
ROE (TTM)	149.7%	-6225.0%
ROA (TTM)	50.0%	-2875.0%
ROIC (TTM)	149.7%	-3438.0%
Financial Health
Cash	$14M	$35M
Debt	$0	$98M
Net Cash/Debt	$14M	$-63M
Current Ratio (TTM)	2.39x	5.19x
Quick Ratio (TTM)	1.03x	4.02x
Debt/Equity (TTM)	0.00x	1.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.01	2.01
52W Performance	-47.7%	-74.4%
YTD Performance	-45.1%	9.5%
% from 52W High	-50.8%	-74.9%
% from 52W Low	28.7%	42.6%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.46x
FCF Yield (TTM)	-9.4%	-51.8%
Earnings Yield (TTM)	19.8%	-98.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8.9	-34.3
EV/GP/RG	0.15	0.04
Ticker research	View LNSR research	View OM research

Valuation

P/E Ratio

LNSR

9.46x

P/S Ratio

0.64x

LNSR

1.30x

EV/FCF

LNSR

-8.82x

-3.56x

Growth & revenue

Revenue Growth TTM

LNSR

3.3%

-1.3%

Forward Revenue Growth

LNSR

20.6%

10.5%

Profitability & performance

Gross Margin

LNSR

46.4%

41.8%

ROE

LNSR

149.7%

-6225.0%

FCF Yield %

LNSR

-9.4%

-51.8%

52-Week Performance

LNSR

-47.7%

-74.4%

Detailed metrics comparison

LNSR

LENSAR Inc

Outset Medical Inc

Market Cap

LNSR$78M

OM$75M

Enterprise Value

LNSR$65M

OM$138M

Price

LNSR$6.37

OM$4.05

P/E Ratio

LNSR9.46x

OMN/A

P/S Ratio

LNSR1.30x

OM0.64x

EV/Sales

LNSR1.07x

OM1.17x

EV/EBITDA

LNSR24.86x

OM0.00x

P/B Ratio

LNSR2.89x

OM0.77x

P/FCF Ratio

LNSRN/A

OMN/A

EV/FCF

LNSR-8.82x

OM-3.56x

PEG Ratio

LNSRN/A

OMN/A

Forward P/E (NTM)

LNSRN/A

OMN/A

Forward P/S (NTM)

LNSR1.12x

OM0.56x

Revenue (TTM)

LNSR$60M

OM$118M

Revenue Growth (YoY)

LNSR3.3%

OM-1.3%

Forward Rev Growth

LNSR20.6%

OM10.5%

Gross Margin (TTM)

LNSR46.4%

OM41.8%

Operating Margin (TTM)

LNSR3.1%

OM0.0%

EBITDA Margin (TTM)

LNSR-7.8%

OM-53.2%

Net Margin (TTM)

LNSR25.7%

OM-63.1%

FCF Margin (TTM)

LNSR-12.2%

OM-33.0%

Net Income (TTM)

LNSR$16M

OM$-74M

FCF (TTM)

LNSR$-7M

OM$-39M

EPS (TTM)

LNSR$0.67

OM-$3.99

ROE (TTM)

LNSR149.7%

OM-6225.0%

ROA (TTM)

LNSR50.0%

OM-2875.0%

ROIC (TTM)

LNSR149.7%

OM-3438.0%

Cash

LNSR$14M

OM$35M

Debt

LNSR$0

OM$98M

Net Cash/Debt

LNSR$14M

OM$-63M

Current Ratio (TTM)

LNSR2.39x

OM5.19x

Quick Ratio (TTM)

LNSR1.03x

OM4.02x

Debt/Equity (TTM)

LNSR0.00x

OM1.02x

Debt/Assets (TTM)

LNSR0.0%

OM0.0%

Interest Coverage (TTM)

LNSRN/A

OMN/A

Net Debt/EBITDA (TTM)

LNSR0.00x

OM0.00x

Beta

LNSR1.01

OM2.01

52W Performance

LNSR-47.7%

OM-74.4%

YTD Performance

LNSR-45.1%

OM9.5%

% from 52W High

LNSR-50.8%

OM-74.9%

% from 52W Low

LNSR28.7%

OM42.6%

Asset Turnover (TTM)

LNSR0.87x

OM0.46x

FCF Yield (TTM)

LNSR-9.4%

OM-51.8%

Earnings Yield (TTM)

LNSR19.8%

OM-98.9%

Dividend Yield (TTM)

LNSRN/A

OMN/A

Rule of 40

LNSR-8.9

OM-34.3

EV/GP/RG

LNSR0.15

OM0.04

Ticker research

View LNSR research View OM research

Metric	LNSR LENSAR Inc	OM Outset Medical Inc
Market & Valuation
Market Cap	$78M	$75M
Enterprise Value	$65M	$138M
Price	$6.37	$4.05
P/E Ratio	9.46x	N/A
P/S Ratio	1.30x	0.64x
EV/Sales	1.07x	1.17x
EV/EBITDA	24.86x	0.00x
P/B Ratio	2.89x	0.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.82x	-3.56x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.12x	0.56x
Revenue & Growth
Revenue (TTM)	$60M	$118M
Revenue Growth (YoY)	3.3%	-1.3%
Forward Rev Growth	20.6%	10.5%
Profitability
Gross Margin (TTM)	46.4%	41.8%
Operating Margin (TTM)	3.1%	0.0%
EBITDA Margin (TTM)	-7.8%	-53.2%
Net Margin (TTM)	25.7%	-63.1%
FCF Margin (TTM)	-12.2%	-33.0%
Net Income (TTM)	$16M	$-74M
FCF (TTM)	$-7M	$-39M
EPS (TTM)	$0.67	-$3.99
ROE (TTM)	149.7%	-6225.0%
ROA (TTM)	50.0%	-2875.0%
ROIC (TTM)	149.7%	-3438.0%
Financial Health
Cash	$14M	$35M
Debt	$0	$98M
Net Cash/Debt	$14M	$-63M
Current Ratio (TTM)	2.39x	5.19x
Quick Ratio (TTM)	1.03x	4.02x
Debt/Equity (TTM)	0.00x	1.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.01	2.01
52W Performance	-47.7%	-74.4%
YTD Performance	-45.1%	9.5%
% from 52W High	-50.8%	-74.9%
% from 52W Low	28.7%	42.6%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.46x
FCF Yield (TTM)	-9.4%	-51.8%
Earnings Yield (TTM)	19.8%	-98.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-8.9	-34.3
EV/GP/RG	0.15	0.04
Ticker research	View LNSR research	View OM research